WHO WE TREAT
Comprehensive Guide to Ibogaine Treatment by David Dardashti
Conditions Treated
David Dardashti’s approach utilizes Ibogaine not merely for detoxification but as a tool for neurological and neurochemical resetting. The clinic addresses a wide spectrum of conditions, primarily categorized into addiction, mental health, and neurological dysfunction.
Addiction
The clinic treats various forms of chemical dependency, viewing addiction as a disruption of the central nervous system’s communication pathways rather than a moral failing.
Opiates & Opioids: This includes addiction to Heroin, Fentanyl, Oxycodone, and Hydrocodone. The treatment aims to reset the brain’s opioid receptors, eliminating physical withdrawal symptoms and significantly reducing cravings.
Suboxone & Methadone: These long-acting opioids present unique challenges due to their long half-lives. The clinic has specialized protocols to handle the complex detoxification required for these substances, often necessitating a more intricate dosing schedule to prevent precipitated withdrawal.
Stimulants: Treatment for Cocaine, Methamphetamine, and Adderall addiction focuses on restoring dopamine production. The clinic describes a “Boost Start” effect, where Ibogaine compresses months of neurochemical healing into a short window, allowing patients to bypass the severe depression and fatigue (anhedonia) associated with stimulant withdrawal.
Alcohol: Ibogaine is used to interrupt the physical dependency on alcohol and repair the liver and neurological damage caused by chronic use. It is positioned as a way to shorten the painful detoxification process and prevent the “Delirium Tremens” associated with severe alcohol withdrawal.
Kratom: While often considered a “safer” alternative, Kratom addiction creates a daily ritualistic trap. The clinic treats Kratom dependency with a specific protocol that ends the daily dosing cycle, often requiring a calculated “washout” period before treatment to ensure safety.
Depression
The clinic distinguishes between two primary types of depression, treating both through neurochemical regulation.
Chemical (Endogenous) Depression: This type is viewed as a biological malfunction where the brain fails to produce or regulate neurotransmitters like serotonin and dopamine correctly. Ibogaine is used to physically “reset” these levels.
Situational (Reactive) Depression: Triggered by external events such as grief, divorce, or career loss. In these cases, Ibogaine is used to help the patient process the emotional trauma attached to the event, effectively “unsticking” the mind from the past.
Trauma and PTSD
Ibogaine is utilized as an oneirogenic (dream-inducing) substance that allows patients to revisit traumatic memories without the attached emotional pain. This detached perspective enables the processing of deep-seated trauma and Post-Traumatic Stress Disorder (PTSD), often resolving issues that years of talk therapy have not addressed.
Executive Burnout
This condition is treated as a physiological state of stress where the body is stuck in “survival mode” (high cortisol). The treatment aims to switch the nervous system back to “healing mode” (parasympathetic activation), restoring mental clarity and energy for high-functioning individuals.
2. Unique Protocols: Doses and Treatment Days
The hallmark of David Dardashti’s method is the Neuro Stimulus Technique, which avoids “one-size-fits-all” dosing in favor of highly personalized protocols.
Algorithmic Dosing
Unlike other clinics that may dose strictly by body weight, David Dardashti utilizes a proprietary algorithm involving mathematics, physics, and Python programming.
Factors Considered: The algorithm calculates the dose based on over a dozen variables, including liver enzyme function (specifically CYP2D6), EKG intervals (cardiac health), age, weight, history of drug use, type of drug, and current toxicity levels.
Pure Ibogaine: The clinic uses pure Ibogaine alkaloids (HCL) rather than raw Iboga root bark. This allows for precise calculation of the active molecule, ensuring safety and efficacy.
Condition-Specific Protocols
Suboxone Protocol: Due to Suboxone’s adhesive nature to brain receptors, the treatment often requires a multi-stage approach. Patients may need to switch to a short-acting opiate prior to treatment or undergo a specialized “washout” protocol. The dosing is often spread out or adjusted to ensure the long-acting metabolites of Suboxone are cleared without precipitating withdrawal.
Stimulant Protocol (“Boost Start”): Focuses on rapid dopamine receptor repair. This protocol is designed to immediately lift the “fog” of Post-Acute Withdrawal Syndrome (PAWS).
Parkinson’s Protocol: Mentioned as a phased approach involving the tapering of existing medications followed by introductory small doses before a “flood dose.” This may require a longer stay to monitor the neurological benefits safely.
Treatment Duration & Dosing Schedule
The Flood Dose: The primary therapeutic session typically lasts 24 to 48 hours. This is the “macrodose” responsible for the intense visionary experience and physical detox.
Booster Doses: Following the initial flood dose, patients often receive micro-doses (boosters) over the subsequent days. These smaller doses are derived proportionately from the initial dose and help to “solidify” the neurological reset, extend the window of neuroplasticity (caused by the metabolite Noribogaine), and prevent post-acute withdrawal symptoms.
Length of Stay: While the active treatment may be short, the clinic emphasizes a stay of several days to a week(e.g., 7 days) to allow for the full integration of the experience, monitoring of vital signs (blood pressure, heart rate), and administration of booster doses.
3. Specific Additional Therapies
To support the heavy neurological work of Ibogaine, the clinic integrates specific therapeutic interventions designed to prepare the body and aid recovery.
Suboxone Transition Therapy: For patients on long-acting opiates, specific medical management is provided to transition them safely toward the Ibogaine treatment window, minimizing discomfort.
Liver Support: Since the liver processes Ibogaine into its long-lasting metabolite Noribogaine, the clinic places heavy emphasis on liver health, utilizing protocols to ensure enzyme function is optimal before and after treatment.
IV Therapy & Electrolytes: Patients are hydrated with electrolyte solutions (such as magnesium and potassium) leading up to and during treatment to maintain cardiac stability and prevent cramping or exhaustion.
4. Various Therapies Involved (Holistic & Integrative)
The clinic adopts a holistic model, recognizing that the “reset” provided by Ibogaine must be supported by physical and environmental therapies.
Physical and Environmental Therapies
Cenote Therapy: Patients visit local freshwater sinkholes (Cenotes) for cold-water therapy. This acts as a natural anti-inflammatory and stimulates the vagus nerve, promoting relaxation and parasympathetic nervous system activation.
Thalassotherapy (Ocean Therapy): Beach walks and swimming are prescribed to utilize the “grounding ions” of the sea and the calming sound of the ocean to lower cortisol levels.
Vitamin D Therapy: Exposure to abundant natural sunlight is used to naturally boost serotonin production, countering depression.
Bodywork and Energy Healing
Massage & Bodywork: Therapies such as deep tissue massage, lymphatic drainage, and relaxation massage are used to release physical tension stored in the body during the detoxification process.
Energy Medicine: Treatments like Reiki and Acupuncture are available to help balance the body’s energy systems and support the emotional release facilitated by the Ibogaine.
Nutritional Therapy
Recovery Diet: The clinic focuses on a diet rich in Omega-3 fatty acids (for brain health), lean proteins (for neurotransmitter production), and complex carbohydrates. Processed sugars and inflammatory foods are strictly avoided to protect the gut-brain axis.
5. Integration and Aftercare
Recovery is viewed as beginning, not ending, at discharge. The clinic outlines a 10-Phase Integration Protocol to ensure long-term success.
The “Clarity Protocol”: A strict zero-tolerance policy for alcohol and marijuana for at least 90 days post-treatment. This protects the liver (which is storing Noribogaine) and the prefrontal cortex (decision-making).
Noribogaine “Afterglow”: Patients are educated on how to utilize the 60-90 day window of heightened neuroplasticity—where the brain is malleable—to form new habits and neural pathways.
Long-Range Telemetry: The clinic coordinates the collection of medical data (liver enzymes, cardiac health) even after the patient returns home to the US, ensuring the biological “reset” is holding
Alumni Network: Access to a community of past patients to combat isolation, which is identified as a primary driver of relapse